LIRAGLUTIDE AS A NOVEL DNA DEMETHYLATING AGENT AND ITS POTENTIAL USE IN THE ADJUVANT TREATMENT OF HIGLY INVASIVE BREAST CANCER
DOI:
https://doi.org/10.29289/259453942019v29s1g13Downloads
Download data is not yet available.
Downloads
Published
2019-09-29
How to Cite
Campos, F. F. de, Chequin, A., Picheth, G., Cavalieri, E. A. S. R., Telles, J. E. Q., Acco, A., … Klassen, G. (2019). LIRAGLUTIDE AS A NOVEL DNA DEMETHYLATING AGENT AND ITS POTENTIAL USE IN THE ADJUVANT TREATMENT OF HIGLY INVASIVE BREAST CANCER. Mastology, 29(3), 14. https://doi.org/10.29289/259453942019v29s1g13
Issue
Section
Geral
License
Copyright (c) 2019 Felipe F. de Campos, Andressa Chequin, Guilherme Picheth, Edneia A. S. R. Cavalieri, José E. Q. Telles, Alexandra Acco, Lucas T. F. Lima, Giseli Klassen

This work is licensed under a Creative Commons Attribution 4.0 International License.




